The stringent processes that ensure new vaccines are clinic-ready Vaccines like any medicinal product need to be manufactured at the highest standard before they are allowed to be tested in humans. Achieving such standards take time, money and careful planning. In this episode we discuss the stringent processes that take a vaccine from a preclinical stage to the clinic ready for vaccination in human subjects. Featuring guest, Emma Bolam.